rs1052553
This is a synonymous variant in the MAPT gene — it does not change the protein's amino acid sequence.
▶GWAS Catalog Trait Associations (1)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (1)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
type 1 diabetes mellitus
▶ClinVar annotation
Frontotemporal dementia (FTD1); MAPT-Related Spectrum Disorders; not specified
View on ClinVar →▶Research that mentions this SNP (1)
▶Independent and joint effects of the MAPT and SNCA genes in Parkinson diseaseAssociationN=9,463Elbaz A. et al.(2011)· Annals of Neurology
This large case-control study of 5,302 Parkinson's disease cases and 4,161 controls from 15 sites examined the independent and joint effects of SNCA and MAPT genes. Four SNCA SNPs (rs2583988, rs181489, rs356219, rs11931074) and two MAPT SNPs (rs1052553, rs242557) were all significantly associated with PD risk, with SNCA variants at the 3' end showing the strongest associations. Notably, no evidence of statistical interaction was found between SNCA and MAPT SNPs on either multiplicative or additive scales, despite their independent contributions to PD susceptibility.
About MAPT
This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
View all MAPT variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…